TCFL5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.506000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.807600E-01
Normal-vs-Stage2
8.757600E-01
Normal-vs-Stage3
3.328800E-01
Normal-vs-Stage4
9.699200E-01
Stage1-vs-Stage2
8.018600E-01
Stage1-vs-Stage3
1.379410E-01
Stage1-vs-Stage4
9.372600E-01
Stage2-vs-Stage3
1.422750E-01
Stage2-vs-Stage4
9.114600E-01
Stage3-vs-Stage4
3.691600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.946000E-01
Normal-vs-AfricanAmerican
8.966400E-01
Normal-vs-Asian
2.508400E-01
Caucasian-vs-AfricanAmerican
8.697800E-01
Caucasian-vs-Asian
3.328000E-02
AfricanAmerican-vs-Asian
8.822200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.234000E-01
Normal-vs-Female
9.981200E-01
Male-vs-Female
7.325400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.033000E-01
Normal-vs-Age(41-60Yrs)
6.547800E-01
Normal-vs-Age(61-80Yrs)
7.068200E-01
Normal-vs-Age(81-100Yrs)
7.658400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.307400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.309200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.771200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.116800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.533600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.820040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.423000E-01
Normal-vs-Daily Drinker
8.669800E-01
Normal-vs-Weekly Drinker
9.118800E-01
Normal-vs-Occasional Drinker
7.919800E-01
Normal-vs-Social Drinker
5.907800E-01
Non Drinker-vs-Daily Drinker
2.687400E-01
Non Drinker-vs-Weekly Drinker
2.437000E-01
Non Drinker-vs-Occasional Drinker
4.271700E-02
Non Drinker-vs-Social Drinker
1.350330E-02
Daily Drinker-vs-Weekly Drinker
6.217000E-01
Daily Drinker-vs-Occasional Drinker
4.091200E-01
Daily Drinker-vs-Social Drinker
1.697190E-01
Weekly Drinker-vs-Occasional Drinker
8.832400E-01
Weekly Drinker-vs-Social Drinker
5.185000E-01
Occasional Drinker-vs-Social Drinker
5.028600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.824200E-01
Normal-vs-Grade 2
7.420600E-01
Normal-vs-Grade 3
7.812800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.141800E-01
Grade 1-vs-Grade 3
9.844800E-01
Grade 1-vs-Grade 4
7.824200E-01
Grade 2-vs-Grade 3
1.027620E-01
Grade 2-vs-Grade 4
7.420600E-01
Grade 3-vs-Grade 4
7.812800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.403000E-01
Normal-vs-NonDiabetic
9.973400E-01
Diabetic-vs-NonDiabetic
2.246000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.826200E-01
Normal-vs-NoPancreatitis
9.293200E-01
Pancreatitis-vs-NoPancreatitis
8.289800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.649400E-01
Normal-vs-N1
8.959600E-01
N0-vs-N1
5.460600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.002000E-01
Normal-vs-TP53-NonMutant
9.816200E-01
TP53-Mutant-vs-TP53-NonMutant
6.206800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
